Cortisol metabolism in critical illness: Implications for clinical care

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 21, Issue 3, 2014, Pages 185-192

  Boonen, Eva ^a   Van Den Berghe, Greet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

cortisol; critical illness; hypothalamic pituitary adrenal axis

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; CORTICOTROPIN; CORTISONE; HYDROCORTISONE; STEROID 5ALPHA REDUCTASE; STEROID 5BETA REDUCTASE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

ADIPOSE TISSUE; ADRENAL DISEASE; CORTICOTROPIN BLOOD LEVEL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIAGNOSIS; DISEASE SEVERITY; HORMONE METABOLISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE METABOLISM; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; METABOLIC REGULATION; NEGATIVE FEEDBACK; PATHOPHYSIOLOGY; PATIENT CARE; PLASMA CLEARANCE; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STRESS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ADRENAL INSUFFICIENCY; DOSE RESPONSE; ENDOCRINE FUNCTION TEST; FEMALE; HYPOPHYSIS ADRENAL SYSTEM; IMMUNOLOGY; INTENSIVE CARE UNIT; MALE; METABOLISM; MORTALITY; TREATMENT OUTCOME;

ADRENAL INSUFFICIENCY; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROCORTISONE; INTENSIVE CARE UNITS; MALE; PITUITARY-ADRENAL FUNCTION TESTS; PITUITARY-ADRENAL SYSTEM; TREATMENT OUTCOME;

EID: 84899932985     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000066     Document Type: Review

References (60)

1. Bertini R, Bianchi M, Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med 1988; 167:1708-1712.
2. Widmer IE, Puder JJ, Konig C, et al. Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab 2005; 90:4579-4586.
3. Annane D. Adrenal insufficiency in sepsis. Curr Pharm Des 2008; 14:1882-1886.
4. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 1937-1949.
5. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009; 135:181-193.
6. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871.
7. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124.
8. Arafah BM. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 2006; 91:3725-3745.
9. Cohen J, Ward G, Prins J, et al. Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population. Intensive Care Med 2006; 32:1901-1905.
10. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350:1629-1638.
11. Vermes I, Beishuizen A, Hampsink RM, Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995; 80:1238-1242.
12. Boonen E, Vervenne H, Meersseman P, et al. Reduced cortisol metabolism during critical illness. N Engl J Med 2013; 368:1477-1488.
13. Deutschman CS, Raj NR, McGuire EO, Kelz MB. Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis. Crit Care Med 2013; 41:e368-e375.
14. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655.
15. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, et al. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 1998; 19: 101-143.
16. Kanczkowski W, Chatzigeorgiou A, Grossklaus S, et al. Role of the endothelial-derived endogenous anti-inflammatory factor Del-1 in inflammationmediated adrenal gland dysfunction. Endocrinology 2013; 154:1181-1189.
17. Kanczkowski W, Alexaki VI, Tran N, et al. Hypothalamo-pituitary and immunedependent adrenal regulation during systemic inflammation. Proc Natl Acad Sci U S A 2013; 110:14801-14806.
18. Langlois VS, Zhang D, Cooke GM, Trudeau VL. Evolution of steroid-5alphareductases and comparison of their function with 5beta-reductase. Gen Comp Endocrinol 2010; 166:489-497.
19. Stimson RH, Andersson J, Andrew R, et al. Cortisol release from adipose tissue by 11 beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes 2009; 58:46-53.
20. Tomlinson JW, Stewart PM. Cortisol metabolism and the role of 11 betahydroxysteroid dehydrogenase. Best Pract Res Clin Endocrinol Metab 2001; 15:61-78.
21. Ackermann D, Vogt B, Escher G, et al. Inhibition of 11 beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis. Hepatology 1999; 30: 623-629.
22. McNeilly AD, Macfarlane DP, O'Flaherty E, et al. Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice. J Hepatol 2010; 52:705-711.
23. Stauffer AT, Rochat MK, Dick B, et al. Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. J Biol Chem 2002; 277:26286-26292.
24. Vanwijngaerden YM, Wauters J, Langouche L, et al. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression. Hepatology 2011; 54:1741-1752.
25. Takigawa T, Miyazaki H, Kinoshita M, et al. Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice. Am J Physiol Gastrointest Liver Physiol 2013; 305:G427-G438.
26. Yehuda R, Bierer LM, Andrew R, et al. Enduring effects of severe developmental adversity, including nutritional deprivation, on cortisol metabolism in aging Holocaust survivors. J Psychiatr Res 2009; 43:877-883.
27. Boyar RM, Hellman LD, Roffwarg H, et al. Cortisol secretion and metabolism in anorexia nervosa. N Engl J Med 1977; 296:190-193.
28. Romer B, Lewicka S, Kopf D, et al. Cortisol metabolism in depressed patients and healthy controls. Neuroendocrinology 2009; 90:301-306.
29. Indyk JA, Candido-Vitto C, Wolf IM, et al. Reduced glucocorticoid receptor protein expression in children with critical illness. Horm Res Paediatr 2013; 79:169-178.
30. van den Akker EL, Koper JW, Joosten K, et al. Glucocorticoid receptor mRNA levels are selectively decreased in neutrophils of children with sepsis. Intensive Care Med 2009; 35:1247-1254
31. Goodwin JE, Feng Y, Velazquez H, Sessa WC. Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Natl Acad Sci U S A 2013; 110:306-311.
32. Coll AP, Challis BG, Yeo GS, et al. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 2004; 145:4721-4727.
33. Barquist E, Kirton O. Adrenal insufficiency in the surgical intensive care unit patient. J Trauma 1997; 42:27-31.
34. Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045.
35. Dellinger RP, Levy MM, Rhodes A, et al. Moreno R: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637.
36. Trainer PJ, Besser M. The Bart's Endocrine Protocols. Edinburgh: Churchill Livingstone; 1995.
37. Sacre K, Dehoux M, Chauveheid MP, et al. Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study. J Clin Endocrinol Metab 2013; 98:3199-3205.
38. Gibbison B, Angelini GD. Lightman SL: dynamic output and control of the hypothalamic-pituitary-adrenal axis in critical illness and major surgery. Br J Anaesth 2013; 111:347-360.
39. Cameron A, Henley D, Carrell R, et al. Temperature-responsive release of cortisol from its binding globulin: a protein thermocouple. J Clin Endocrinol Metab 2010; 95:4689-4695.
40. Chan WL, Carrell RW, Zhou A, Read RJ. How changes in affinity of corticosteroid-binding globulin modulate free cortisol concentration. J Clin Endocrinol Metab 2013; 98:3315-3322.
41. Holland PC, Hancock SW, Hodge D, et al. Degradation of albumin in meningococcal sepsis. Lancet 2001; 357:2102-2104.
42. Pugeat M, Bonneton A, Perrot D, et al. Decreased immunoreactivity and binding activity of corticosteroid-binding globulin in serum in septic shock. Clin Chem 1989; 35:1675-1679.
43. Bergquist M, Nurkkala M, Rylander C, et al. Expression of the glucocorticoid receptor is decreased in experimental Staphylococcus aureus sepsis. J Infect 2013; 67:574-583.
44. Guerrero J, Gatica HA, Rodriguez M, Estay R. Goecke IA: septic serum induces glucocorticoid resistance and modifies the expression of glucocorticoid isoforms receptors: a prospective cohort study and in vitro experimental assay. Crit Care 2013; 17:R107.
45. Peeters RP, Hagendorf A, Vanhorebeek I, et al. Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness. Clin Endocrinol (Oxf) 2009; 71:145-153.
46. Siebig S, Meinel A, Rogler G, et al. Decreased cytosolic glucocorticoid receptor levels in critically ill patients. Anaesth Intensive Care 2010; 38:133-140.
47. Stenman UH. Standardization of hormone determinations. Best Pract Res Clin Endocrinol Metab 2013; 27:823-830.
48. Keevil BG. Novel liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for measuring steroids. Best Pract Res Clin Endocrinol Metab 2013; 27:663-674.
49. Vassiliadi DA, Ilias I, Tzanela M, et al. Interstitial cortisol obtained by microdialysis in mechanically ventilated septic patients: correlations with total and free serum cortisol. J Crit Care 2013; 28:158-165.
50. Venkatesh B, Morgan TJ, Cohen J. Interstitium: the next diagnostic and therapeutic platform in critical illness. Crit Care Med 2010; 38:S630-S636.
51. Trzeciak S, Dellinger RP, Parrillo JE, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007; 49:88-98; 98.
52. Kraan GP, Dullaart RP, Pratt JJ, et al. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. J Clin Endocrinol Metab 1998; 83:1247-1252.
53. Vanhorebeek I, Peeters RP, Vander Perre S, et al. Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab 2006; 91:3803-3813.
54. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007; 175:480-489.
55. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Clinical review: critical illness polyneuropathy and myopathy. Crit Care 2008; 12: 238.
56. Hauer D, Weis F, Papassotiropoulos A, et al. Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Crit Care Med 2011; 39:643-650.
57. Ledderose C, Mohnle P, Limbeck E, et al. Corticosteroid resistance in sepsis is influenced by microRNA-124-induced downregulation of glucocorticoid receptor-alpha. Crit Care Med 2012; 40:2745-2753.
58. Baker AC, Chew VW, Green TL, et al. Single nucleotide polymorphisms and type of steroid impact the functional response of the human glucocorticoid receptor. J Surg Res 2013; 180:27-34.
59. Baker AC, Green TL, Chew VW, et al. Enhanced steroid response of a human glucocorticoid receptor splice variant. Shock 2012; 38:11-17.
60. Venkatesh B, Myburgh J, Finfer S, et al. The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock. Crit Care Resusc 2013; 15:83-88.